Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2020 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Hordenine inhibits neuroinflammation and exerts neuroprotective effects via inhibiting NF-κB and MAPK signaling pathways in vivo and in vitro.
Int Immunopharmacol. 2022 Jul;108:108694. doi: 10.1016/j.intimp.2022.108694. Epub 2022 Mar 26.
Int Immunopharmacol. 2022.
PMID: 35349959
Beta-naphthoflavone inhibits LPS-induced inflammation in BV-2 cells via AKT/Nrf-2/HO-1-NF-κB signaling axis.
Gao X, He D, Liu D, Hu G, Zhang Y, Meng T, Su Y, Zhou A, Huang B, Du J, Fu S.
Gao X, et al.
Immunobiology. 2020 Jul;225(4):151965. doi: 10.1016/j.imbio.2020.151965. Epub 2020 May 28.
Immunobiology. 2020.
PMID: 32747020
Item in Clipboard
Farrerol Ameliorates TNBS-Induced Colonic Inflammation by Inhibiting ERK1/2, JNK1/2, and NF-κB Signaling Pathway.
Ran X, Li Y, Chen G, Fu S, He D, Huang B, Wei L, Lin Y, Guo Y, Hu G.
Ran X, et al.
Int J Mol Sci. 2018 Jul 13;19(7):2037. doi: 10.3390/ijms19072037.
Int J Mol Sci. 2018.
PMID: 30011811
Free PMC article.
Item in Clipboard
Corrigendum to 'Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways'. [Int. Immunopharmacol. 75 (2019) 105739].
Li Y, Zeng Y, Meng T, Gao X, Huang B, He D, Ran X, Du J, Zhang Y, Fu S, Hu G.
Li Y, et al.
Int Immunopharmacol. 2020 Jul;84:105962. doi: 10.1016/j.intimp.2019.105962. Epub 2020 Jan 13.
Int Immunopharmacol. 2020.
PMID: 31948857
No abstract available.
Item in Clipboard
Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
Li Y, Zeng Y, Meng T, Gao X, Huang B, He D, Ran X, Du J, Zhang Y, Fu S, Hu G.
Li Y, et al.
Int Immunopharmacol. 2019 Oct;75:105739. doi: 10.1016/j.intimp.2019.105739. Epub 2019 Jul 24.
Int Immunopharmacol. 2019.
PMID: 31351366
Item in Clipboard
Cite
Cite